Go Local And Stay Flexible: Unlocking Market Access For Novel Drugs In China

Although regulatory improvement in China has raised hopes that more novel drugs will enter the market, a lack of reimbursement and rounds of price negotiations still pose challenges. A recent report sheds lights on some remedies for policy makers and drug makers.